Dimethyl fumarate (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Dimethyl fumarate" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
18th place
17th place
3,823rd place
2,387th place
11th place
8th place
3rd place
3rd place
14th place
14th place
low place
low place
5th place
5th place
low place
low place
low place
low place
low place
low place
low place
low place
1,160th place
737th place
low place
6,978th place
low place
low place
49th place
47th place
2,737th place
1,700th place
4,509th place
2,517th place
low place
low place
archive.today (Global: 14th place; English: 14th place)
- McEntee J. "Fumaderm: what is the evidence for its efficacy and safety". North West Medicines Information Centre. Archived from the original on 5 May 2013. Retrieved 29 November 2012.
barrons.com (Global: 2,737th place; English: 1,700th place)
- Alpert B. "Biogen Stock Is Slumping After Judge Rules Against Its Biggest Drug". Barron's. Retrieved 19 June 2020.
bbc.co.uk (Global: 8th place; English: 10th place)
news.bbc.co.uk
- "Judge rejects 'toxic sofa' claims in burns injury cases". BBC. 18 March 2010.
- "Huge law suit over 'toxic sofas'". BBC. 19 December 2008.
bbc.co.uk
- "Consumer – TV and radio – itchy sofas". BBC. Archived from the original on 22 February 2008.
biogen.com (Global: low place; English: low place)
investors.biogen.com
- "Biogen and Alkermes Announce FDA Approval of Vumerity (diroximel fumarate) for Multiple Sclerosis". Biogen. Retrieved 21 February 2020.
biopharmadive.com (Global: low place; English: low place)
- "Biogen loses patent dispute with Mylan, putting its top drug's future in doubt". BioPharma Dive. Retrieved 19 June 2020.
biotechtranslated.com (Global: low place; English: low place)
- Hamilton M (13 September 2012). "Just how much profit is there in a new drug?". Biotech Translated.
books.google.com (Global: 3rd place; English: 3rd place)
- Al-Jaderi Z, Maghazachi AA (2016). "Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases". Frontiers in Immunology. 7: 278. doi:10.3389/fimmu.2016.00278. PMC 4956641. PMID 27499754.
- Ettmayer P, Schnitzer R, Bergner A, Nar H (2017). "Chapter 2.02: Hit and Lead Generation Strategies". In Chackalamannil S, Rotella D, Ward S, Martinez A, Gil C (eds.). Comprehensive Medicinal Chemistry III: Volume 2: Drug Discovery Technologies. Elsevier. p. 58. ISBN 978-0-12-803201-5.
doi.org (Global: 2nd place; English: 2nd place)
- Linker RA, Haghikia A (July 2016). "Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy". Therapeutic Advances in Chronic Disease. 7 (4): 198–207. doi:10.1177/2040622316653307. PMC 4935836. PMID 27433310.
- Mrowietz U, Altmeyer P, Bieber T, Röcken M, Schopf RE, Sterry W (August 2007). "Treatment of psoriasis with fumaric acid esters (Fumaderm)". Journal der Deutschen Dermatologischen Gesellschaft. 5 (8): 716–717. doi:10.1111/j.1610-0387.2007.06346.x. PMID 17659047. S2CID 7431706.
- Xu Z, Zhang F, Sun F, Gu K, Dong S, He D (22 April 2015). "Dimethyl fumarate for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2015 (4) CD011076. doi:10.1002/14651858.CD011076.pub2. ISSN 1469-493X. PMC 10663978. PMID 25900414.
- Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer C, Shetty A, Sagan S, et al. (26 April 2016). "Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2". Proceedings of the National Academy of Sciences of the United States of America. 113 (17): 4777–4782. Bibcode:2016PNAS..113.4777S. doi:10.1073/pnas.1603907113. PMC 4855599. PMID 27078105.
- Ntranos A, Ntranos V, Bonnefil V, Liu J, Kim-Schulze S, He Y, et al. (March 2019). "Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis". Brain: A Journal of Neurology. 142 (3): 647–661. doi:10.1093/brain/awy344. PMC 6821213. PMID 30698680.
- Love BE, Bennett LJ (October 2017). "Two approaches to the synthesis of dimethyl fumarate that demonstrate fundamental principles of organic chemistry". Journal of Chemical Education. 94 (10): 1543–1546. Bibcode:2017JChEd..94.1543L. doi:10.1021/acs.jchemed.6b00818.
- Ledlie DB, Wenzel TJ, Hendrickson SM (1989). "Isomerization of dimethyl maleate to dimethyl fumarate: An undergraduate experiment utilizing high performance liquid chromatography". Journal of Chemical Education. 66 (9): 781. Bibcode:1989JChEd..66..781L. doi:10.1021/ed066p781.
- Fryhle CB, Rybak CM, Pulley KE (1991). "Isomerization of dimethyl maleate to dimethyl fumarate: An undergraduate experiment illustrating amine-catalyzed alkene isomerization, stereochemical principles, sublimation, and product identification by spectroscopic methods". Journal of Chemical Education. 68 (12): 1050. Bibcode:1991JChEd..68.1050F. doi:10.1021/ed068p1050.
- White DA (1981). "Electrohydrodimerization of an Activated Alkene: Tetraethyl 1,2,3,4-Butanetetracarboxylate". Organic Syntheses. 60: 58. doi:10.15227/orgsyn.060.0058.
- Al-Jaderi Z, Maghazachi AA (2016). "Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases". Frontiers in Immunology. 7: 278. doi:10.3389/fimmu.2016.00278. PMC 4956641. PMID 27499754.
- Lijnen R, Otters E, Balak D, Thio B (2016). "Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study". The Journal of Dermatological Treatment. 27 (1): 31–6. doi:10.3109/09546634.2015.1050980. PMID 26088405.
- Blair HA (January 2018). "Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis". Drugs. 78 (1): 123–130. doi:10.1007/s40265-017-0854-6. PMID 29236231.
- Burke M, Richardson J, George E, Adler A (November 2014). "Dimethyl fumarate for relapsing-remitting multiple sclerosis". The Lancet. Neurology. 13 (11): 1077–1078. doi:10.1016/S1474-4422(14)70159-0. PMID 28845815.
- Rantanen T (July 2008). "The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer". The British Journal of Dermatology. 159 (1): 218–221. doi:10.1111/j.1365-2133.2008.08622.x. PMID 18503603. S2CID 45134115.
- Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, et al. (January 2024). "Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Nature Communications. 15 (1) 924. doi:10.1038/s41467-023-43644-x. PMC 10831058. PMID 38296965.
europa.eu (Global: 68th place; English: 117th place)
ema.europa.eu
- "Tecfidera EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 25 May 2022.
- "Skilarence EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 25 May 2022.
- "Dimethyl fumarate Accord EPAR". European Medicines Agency. 12 October 2022. Retrieved 22 February 2023.
- "Agency EM. Skilarence [Updated]". 17 September 2018. Archived from the original on 20 June 2018. Retrieved 26 February 2019.
- "Skilarence Summary of Product Characteristics" (PDF). May 2018. Archived from the original (PDF) on 18 June 2018. Retrieved 26 February 2019.
echa.europa.eu
- "Background document to the opinions on the Annex XV dossier proposing restrictions on Dimethylfumarate (DMFu)" (PDF). European Chemicals Agency. 16 March 2011. p. 9. Archived from the original (PDF) on 22 February 2021. Retrieved 19 July 2018.
ec.europa.eu
- "Consumers: EU to ban dimethylfumarate (DMF) in consumer products, such as sofas and shoes" (Press release). European Commission. Retrieved 29 November 2012.
eur-lex.europa.eu
fda.gov (Global: 447th place; English: 338th place)
fda.gov
- "Office of Generic Drugs 2020 Annual Report". U.S. Food and Drug Administration (FDA). Archived from the original on 12 February 2021. Retrieved 12 February 2021.
- "FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)". fda.gov. Archived from the original on 28 November 2014. Retrieved 2 December 2014.
- "FDA approves new multiple sclerosis treatment: Tecfidera". FDA. 27 March 2013. Archived from the original on 29 March 2013. Retrieved 5 April 2013.
accessdata.fda.gov
- "Drug Approval Package: Vumerity". U.S. Food and Drug Administration (FDA). 21 April 2020. Archived from the original on 30 June 2020. Retrieved 1 February 2021.
harvard.edu (Global: 18th place; English: 17th place)
ui.adsabs.harvard.edu
- Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer C, Shetty A, Sagan S, et al. (26 April 2016). "Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2". Proceedings of the National Academy of Sciences of the United States of America. 113 (17): 4777–4782. Bibcode:2016PNAS..113.4777S. doi:10.1073/pnas.1603907113. PMC 4855599. PMID 27078105.
- Love BE, Bennett LJ (October 2017). "Two approaches to the synthesis of dimethyl fumarate that demonstrate fundamental principles of organic chemistry". Journal of Chemical Education. 94 (10): 1543–1546. Bibcode:2017JChEd..94.1543L. doi:10.1021/acs.jchemed.6b00818.
- Ledlie DB, Wenzel TJ, Hendrickson SM (1989). "Isomerization of dimethyl maleate to dimethyl fumarate: An undergraduate experiment utilizing high performance liquid chromatography". Journal of Chemical Education. 66 (9): 781. Bibcode:1989JChEd..66..781L. doi:10.1021/ed066p781.
- Fryhle CB, Rybak CM, Pulley KE (1991). "Isomerization of dimethyl maleate to dimethyl fumarate: An undergraduate experiment illustrating amine-catalyzed alkene isomerization, stereochemical principles, sublimation, and product identification by spectroscopic methods". Journal of Chemical Education. 68 (12): 1050. Bibcode:1991JChEd..68.1050F. doi:10.1021/ed068p1050.
leaddiscovery.blogspot.com (Global: low place; English: low place)
- Goldhill J (15 September 2015). "Disappointing Phase 2 psoriasis data reported for the monomethyl fumarate prodrug, XP23829". Advances in drug discovery.
medicines.org.uk (Global: 3,823rd place; English: 2,387th place)
- "Skilarence 120 mg Gastro-resistant Tablets - Summary of Product Characteristics". Electronic Medicines Compendium. May 2018. Retrieved 19 July 2018.
- "Tecfidera 120mg and 240mg gastro-resistant hard capsules - Summary of Product Characteristics". Electronic Medicines Compendium. February 2018. Retrieved 19 July 2018.
multiplesclerosisnewstoday.com (Global: low place; English: low place)
- "Vumerity (Previously BIIB098 and ALKS 8700)". Multiple Sclerosis News Today. 1 November 2019. Retrieved 21 February 2020.
nelm.nhs.uk (Global: low place; English: low place)
- McEntee J. "Fumaderm: what is the evidence for its efficacy and safety". North West Medicines Information Centre. Archived from the original on 5 May 2013. Retrieved 29 November 2012.
nih.gov (Global: 4th place; English: 4th place)
pubmed.ncbi.nlm.nih.gov
- Linker RA, Haghikia A (July 2016). "Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy". Therapeutic Advances in Chronic Disease. 7 (4): 198–207. doi:10.1177/2040622316653307. PMC 4935836. PMID 27433310.
- Mrowietz U, Altmeyer P, Bieber T, Röcken M, Schopf RE, Sterry W (August 2007). "Treatment of psoriasis with fumaric acid esters (Fumaderm)". Journal der Deutschen Dermatologischen Gesellschaft. 5 (8): 716–717. doi:10.1111/j.1610-0387.2007.06346.x. PMID 17659047. S2CID 7431706.
- Xu Z, Zhang F, Sun F, Gu K, Dong S, He D (22 April 2015). "Dimethyl fumarate for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2015 (4) CD011076. doi:10.1002/14651858.CD011076.pub2. ISSN 1469-493X. PMC 10663978. PMID 25900414.
- Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer C, Shetty A, Sagan S, et al. (26 April 2016). "Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2". Proceedings of the National Academy of Sciences of the United States of America. 113 (17): 4777–4782. Bibcode:2016PNAS..113.4777S. doi:10.1073/pnas.1603907113. PMC 4855599. PMID 27078105.
- Ntranos A, Ntranos V, Bonnefil V, Liu J, Kim-Schulze S, He Y, et al. (March 2019). "Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis". Brain: A Journal of Neurology. 142 (3): 647–661. doi:10.1093/brain/awy344. PMC 6821213. PMID 30698680.
- Al-Jaderi Z, Maghazachi AA (2016). "Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases". Frontiers in Immunology. 7: 278. doi:10.3389/fimmu.2016.00278. PMC 4956641. PMID 27499754.
- Lijnen R, Otters E, Balak D, Thio B (2016). "Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study". The Journal of Dermatological Treatment. 27 (1): 31–6. doi:10.3109/09546634.2015.1050980. PMID 26088405.
- Blair HA (January 2018). "Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis". Drugs. 78 (1): 123–130. doi:10.1007/s40265-017-0854-6. PMID 29236231.
- Burke M, Richardson J, George E, Adler A (November 2014). "Dimethyl fumarate for relapsing-remitting multiple sclerosis". The Lancet. Neurology. 13 (11): 1077–1078. doi:10.1016/S1474-4422(14)70159-0. PMID 28845815.
- Rantanen T (July 2008). "The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer". The British Journal of Dermatology. 159 (1): 218–221. doi:10.1111/j.1365-2133.2008.08622.x. PMID 18503603. S2CID 45134115.
- Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, et al. (January 2024). "Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Nature Communications. 15 (1) 924. doi:10.1038/s41467-023-43644-x. PMC 10831058. PMID 38296965.
ncbi.nlm.nih.gov
- Linker RA, Haghikia A (July 2016). "Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy". Therapeutic Advances in Chronic Disease. 7 (4): 198–207. doi:10.1177/2040622316653307. PMC 4935836. PMID 27433310.
- Xu Z, Zhang F, Sun F, Gu K, Dong S, He D (22 April 2015). "Dimethyl fumarate for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2015 (4) CD011076. doi:10.1002/14651858.CD011076.pub2. ISSN 1469-493X. PMC 10663978. PMID 25900414.
- Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer C, Shetty A, Sagan S, et al. (26 April 2016). "Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2". Proceedings of the National Academy of Sciences of the United States of America. 113 (17): 4777–4782. Bibcode:2016PNAS..113.4777S. doi:10.1073/pnas.1603907113. PMC 4855599. PMID 27078105.
- Ntranos A, Ntranos V, Bonnefil V, Liu J, Kim-Schulze S, He Y, et al. (March 2019). "Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis". Brain: A Journal of Neurology. 142 (3): 647–661. doi:10.1093/brain/awy344. PMC 6821213. PMID 30698680.
- Al-Jaderi Z, Maghazachi AA (2016). "Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases". Frontiers in Immunology. 7: 278. doi:10.3389/fimmu.2016.00278. PMC 4956641. PMID 27499754.
- Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, et al. (January 2024). "Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial". Nature Communications. 15 (1) 924. doi:10.1038/s41467-023-43644-x. PMC 10831058. PMID 38296965.
dailymed.nlm.nih.gov
- "Tecfidera- dimethyl fumarate kit Tecfidera- dimethyl fumarate capsule". DailyMed. Retrieved 13 February 2021.
nottinghampost.com (Global: 4,509th place; English: 2,517th place)
- "Clifton woman's toxic sofa claim". The Nottingham Post. Local World. 2 April 2009.[permanent dead link]
recoverytrial.net (Global: low place; English: low place)
- "RECOVERY trial closes recruitment to colchicine treatment for patients hospitalised with COVID-19". Nuffield Department of Population Health, University of Oxford. 5 March 2021.
reuters.com (Global: 49th place; English: 47th place)
- "BRIEF-Biogen Says To Appeal Court Decision Regarding Patent Related To Tecfidera". Reuters. 18 June 2020. Retrieved 19 June 2020.
science.org (Global: 1,160th place; English: 737th place)
- Lowe D (2 April 2013). "Tecfidera's Price". In the Pipeline. Archived from the original on 11 November 2020. Retrieved 19 July 2018.
semanticscholar.org (Global: 11th place; English: 8th place)
api.semanticscholar.org
- Mrowietz U, Altmeyer P, Bieber T, Röcken M, Schopf RE, Sterry W (August 2007). "Treatment of psoriasis with fumaric acid esters (Fumaderm)". Journal der Deutschen Dermatologischen Gesellschaft. 5 (8): 716–717. doi:10.1111/j.1610-0387.2007.06346.x. PMID 17659047. S2CID 7431706.
- Rantanen T (July 2008). "The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer". The British Journal of Dermatology. 159 (1): 218–221. doi:10.1111/j.1365-2133.2008.08622.x. PMID 18503603. S2CID 45134115.
web.archive.org (Global: 1st place; English: 1st place)
- "Background document to the opinions on the Annex XV dossier proposing restrictions on Dimethylfumarate (DMFu)" (PDF). European Chemicals Agency. 16 March 2011. p. 9. Archived from the original (PDF) on 22 February 2021. Retrieved 19 July 2018.
- "Agency EM. Skilarence [Updated]". 17 September 2018. Archived from the original on 20 June 2018. Retrieved 26 February 2019.
- "Office of Generic Drugs 2020 Annual Report". U.S. Food and Drug Administration (FDA). Archived from the original on 12 February 2021. Retrieved 12 February 2021.
- "FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)". fda.gov. Archived from the original on 28 November 2014. Retrieved 2 December 2014.
- "Skilarence Summary of Product Characteristics" (PDF). May 2018. Archived from the original (PDF) on 18 June 2018. Retrieved 26 February 2019.
- "Drug Approval Package: Vumerity". U.S. Food and Drug Administration (FDA). 21 April 2020. Archived from the original on 30 June 2020. Retrieved 1 February 2021.
- Lowe D (2 April 2013). "Tecfidera's Price". In the Pipeline. Archived from the original on 11 November 2020. Retrieved 19 July 2018.
- "FDA approves new multiple sclerosis treatment: Tecfidera". FDA. 27 March 2013. Archived from the original on 29 March 2013. Retrieved 5 April 2013.
- "Consumer – TV and radio – itchy sofas". BBC. Archived from the original on 22 February 2008.
worldcat.org (Global: 5th place; English: 5th place)
search.worldcat.org
- Xu Z, Zhang F, Sun F, Gu K, Dong S, He D (22 April 2015). "Dimethyl fumarate for multiple sclerosis". The Cochrane Database of Systematic Reviews. 2015 (4) CD011076. doi:10.1002/14651858.CD011076.pub2. ISSN 1469-493X. PMC 10663978. PMID 25900414.
xconomy.com (Global: low place; English: 6,978th place)
- Vinluan F (17 January 2017). "Xconomy: Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug". Xconomy.
yle.fi (Global: 380th place; English: 933rd place)
- "Myrkkytuoli-ihottumien syy selvisi". YLE Uutiset (in Finnish). YLE. 24 April 2008. Retrieved 10 June 2008.